Evidence map›Paper›PMID 35169328›Full record

ArticleCirugia espanola2023

Has the COVID-19 pandemic changed the clinical picture and tumour stage at the time of presentation of patients with colorectal cancer? A retrospective cohort study.

Oscar Cano-Valderrama, Raquel Sánchez-Santos, Vincenzo Vigorita, Marta Paniagua, Erene Flores, Lucia Garrido, Cristina Facal, Alejandro Ruano, Alberto San-Ildefonso, Enrique Moncada

Open access · greenAbstract read
In one paragraph

Article in Cirugia espanola, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Oscar Cano-ValderramaDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Raquel Sánchez-SantosDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Vincenzo VigoritaDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Marta PaniaguaDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Erene FloresDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Lucia GarridoDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Cristina FacalDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Alejandro RuanoDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Alberto San-IldefonsoDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Enrique MoncadaDepartment of Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
University Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Treatment of patients with Coronavirus Disease 2019 (COVID-19) has affected the management of patients with colorectal cancer (CRC). The aim of this study was to compare the diagnosis delay, symptoms, and stage of patients with CRC during the pandemic with a control cohort. Material and methods: Patients referred to the CRC multidisciplinary team between September 2019 and January 2020 (cohort 1, control group) were compared with those who presented between September 2020 and March 2021 (cohort 2, pandemic group). Results: 389 patients were included, 169 in cohort 1 and 220 in cohort 2. No differences were observed in the main characteristics of the patients. CRC screening and anaemia were the most common causes leading to the diagnosis of the tumour in cohort 1 and 2, respectively ( Conclusion: CRC patients in the pandemic cohort had a longer diagnostic and therapeutic delay and less patients were diagnosed because of CRC screening. In addition, patients with CRC during the pandemic needed non-elective treatment more frequently than patients in the control cohort, and their tumour stage tended to be more advanced.

Indexed as

Colon cancerColorectal cancerCOVID-19Diagnosis delayPandemic

Identifiers

PMID35169328
PMCPMC8831139
OpenAlexW4211207282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.